Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
The standard of care for pancreatic cancer has remained largely unchanged for the past two decades, but now scientists have identified 10 different genetic pathways driving the disease,…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week, The Doctor's Channel and IMS Health's Appscript.net present you with a useful and thoughtfully designed app that can help both patients and their physicians with health-related…
Administering two types of immunotherapy drugs concurrently has paused or reversed malignant tumor growth in almost sixty percent of patients participating in a UK clinical trial.
Rebecca Kaltman, MD, feeling frustrated with the limitations and shortcomings of a traditional medical practice, decided to found Breast Cancer Consultants – an online, direct-to-patient, breast cancer consultation…
Patients that have been diagnosed with breast cancer often end up with a cumbersome amount of appointments with their physicians and specialists. Many of these doctor visits could…
Incorporating elements of telemedicine into a traditional practice can improve a physician’s work-life balance while simultaneously improving their patients’ experiences. There are many patient appointments that don’t necessarily…
